|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-9-26
|
|
pubmed:abstractText |
Transfersome is a drug delivery technology based on highly deformable, ultraflexible lipid vesicles which penetrate the skin when applied non-occlusively.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
149
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
611-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14510997-Administration, Topical,
pubmed-meshheading:14510997-Adult,
pubmed-meshheading:14510997-Anti-Inflammatory Agents,
pubmed-meshheading:14510997-Atrophy,
pubmed-meshheading:14510997-Dose-Response Relationship, Drug,
pubmed-meshheading:14510997-Double-Blind Method,
pubmed-meshheading:14510997-Drug Carriers,
pubmed-meshheading:14510997-Emollients,
pubmed-meshheading:14510997-Humans,
pubmed-meshheading:14510997-Lipids,
pubmed-meshheading:14510997-Middle Aged,
pubmed-meshheading:14510997-Odds Ratio,
pubmed-meshheading:14510997-Ointments,
pubmed-meshheading:14510997-Risk Assessment,
pubmed-meshheading:14510997-Skin,
pubmed-meshheading:14510997-Triamcinolone Acetonide
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Improved risk-benefit ratio for topical triamcinolone acetonide in Transfersome in comparison with equipotent cream and ointment: a randomized controlled trial.
|
|
pubmed:affiliation |
Department of Dermatology and Allergy, Technical University Munich, Biedersteinerstr. 29, 80802 Munich, Germany. heike.fesq@lrz.tu-muenchen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
